Lifeboat Foundation

https://www.youtube.com/watch?v=4Z8GRrN9N0w&feature=share

If new cells, with new DNA, RNA polymerases and nucleotides can be generated to replace the cells affected by the virus, the enzyme of the virus can be eliminated, and the virus will be unable to make copies of its RNA. This can be done by stimulating the stem cells to become cells with new DNA, RNA, proteins, and nucleotides. Stem Cell Neurotherapy sends therapeutic messages to the DNA inside the stem cells’ nucleus. DNA sends the information to the RNA molecules called messenger RNA. The transfer RNA synthesizes proteins to carry out the instructions given by messenger RNA templates for the stem cells to become new cells and tissues to replace those infected by the coronavirus. We have produced and developed Stem Cell Neurotherapy for COVID-19 patients. The therapy is designed to help the patients generate new cells in their lungs, liver, kidney, and other organs to replace those cells that have been infected by COVID-19. These new cells will eliminate the fever, coughing, headaches, breathing problems, and other symptoms related to COVID-19. More details are at: Stem Cell Neurotherapy on Facebook…

How did a U.S. patient in a New Jersey hospital become the first presumed Covid 19 respiratory failure patient in the world to receive stem cell exosomes? Get the inside scoop!

Cancer cells have the extraordinary evolutionary potential to adapt and acquire resistance to most conventional and targeted therapies. In a new study, Lin et al., develop a systematic approach to identify combination therapies that produce cancer traps, in which evading the first drug makes the cancer vulnerable to the second.

In addition to self isolation, widespread testing to identify asymptomatic spreaders is needed. YaleNews:

The conclusion of a new Yale-led study is clear: Without dramatic action, there won’t be enough beds for the sickest COVID-19 patients.

We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.

Copyright © 2020 Elsevier B.V. or its licensors or contributors. ScienceDirect ® is a registered trademark of Elsevier B.V.

ScienceDirect ® is a registered trademark of Elsevier B.V.

This is the latest Lifeboat Foundation update on our worldwide pandemic.

It is also at https://www.facebook.com/groups/lifeboatfoundation/permalink/10158811699298455.

Key summary of this report:

Continue reading “Coronavirus Update III” »

https://youtube.com/watch?v=tPx1yqvJgf4

Don’t despair: In just 45 seconds, U.S. Surgeon General Dr. Jerome Adams demonstrates how to make your own cloth facemask.

It’s lo-tech. You can use a T-shirt, hand towel, or bandana. The only other thing you need is rubber bands.

Continue reading “CDC shows you how to make a face mask in 45 seconds” »

The ongoing fight against the COVID-19 pandemic could get a boost if Canadians paid more attention to the relative humidity levels in public and private spaces, according to a growing body of international research.

Doctors, scientists and engineers agree that sufficient indoor air moisture levels can have a powerful but little-understood effect on the transmission of airborne diseases. While the novel coronavirus that causes COVID-19 is currently treated as one that’s transmitted through droplet infection rather than the air, research on exactly how it passes between humans is still underway.

Most buildings, however, fall short of the recommended threshold of 40 to 60 per cent relative humidity, particularly in countries with colder, dryer climates such as Canada.

The human cerebral cortex is important for cognition, and it is of interest to see how genetic variants affect its structure. Grasby et al. combined genetic data with brain magnetic resonance imaging from more than 50,000 people to generate a genome-wide analysis of how human genetic variation influences human cortical surface area and thickness. From this analysis, they identified variants associated with cortical structure, some of which affect signaling and gene expression. They observed overlap between genetic loci affecting cortical structure, brain development, and neuropsychiatric disease, and the correlation between these phenotypes is of interest for further study.

Science, this issue p. eaay6690.

An international team led by University of British Columbia researcher Dr. Josef Penninger has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts.

The findings, published today in Cell, hold promise as a treatment capable of stopping early infection of the novel coronavirus that, as of April 2, has affected more than 981,000 people and claimed the lives of 50,000 people worldwide.